Autoantibodies to glutamate receptor antigens in multiple sclerosis and Rasmussen's encephalitis
Juergen Trippe1, Katja Steinke, Angela Orth
1Department of Receptor Biochemistry, Ruhr University Bochum, Bochum, Germany.
Neuroimmunomodulation
|February 8, 2014
Summary
Autoantibodies against glutamate receptors (GluR) were investigated in multiple sclerosis (MS). While found in some MS patients and healthy donors, these antibodies, primarily targeting GluN1, were not statistically significant and may be an immune epiphenomenon.
Area of Science:
- Neuroscience
- Immunology
- Neurology
Background:
- Glutamate receptors (GluR) are crucial for neuronal function and implicated in neurodegeneration and regeneration.
- Autoantibodies (aab) to GluR are known in neurological diseases like Rasmussen's encephalitis (RE), but their role in multiple sclerosis (MS) is unstudied.
Purpose of the Study:
- To investigate the presence and potential role of anti-GluR autoantibodies in patients with relapsing-remitting MS.
- To compare anti-GluR autoantibody levels in MS patients, RE patients, and healthy donors.
Main Methods:
- Serum samples from 56 individuals (25 MS, 8 RE, 23 healthy donors) were analyzed.
- Immunoblot analysis was performed using recombinantly expressed GluR proteins (GluN1, GluN2C, GluA3, GluK2, GluD2).
Main Results:
- Autoantibodies were primarily detected against GluN1 in both MS patients (32%) and healthy donors (26%), a difference that was not statistically significant.
- No anti-GluR autoantibodies were found in patients with RE.
- Low prevalence of antibodies against GluK2 and GluA3 was observed in one MS patient and two healthy donors, respectively.
Conclusions:
- Anti-GluR autoantibodies, mainly targeting GluN1, are detectable in MS patients and healthy donors but not in RE patients.
- These antibodies may possess low affinity and titer, potentially representing an immune epiphenomenon.
- Further research is needed to determine if these antibodies serve as markers for neuronal damage or regeneration in MS.
More Related Videos
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20
01:26Encephalitis ll: Pathophysiology
22
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
22
01:19Encephalitis l: Introduction
15
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
15
01:22Myasthenia Gravis ll: Pathophysiology
53
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
53
01:15Myasthenia Gravis: Diagnostic Tests
3.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.3K
01:14Antiepileptic Drugs: Glutamate Antagonists
1.3K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K